# A Phase I, Prospective, Randomized, Open-label, Active-Controlled Clinical Trial for Safety Evaluation of Intra-articular Injection of RegenoGel-SP for the Treatment of Moderate to Severe Osteoarthritis

> **NCT02188771** · PHASE1,PHASE2 · COMPLETED · sponsor: **ProCore Ltd.** · enrollment: 11 (actual)

## Conditions studied

- Osteoarthritis

## Interventions

- **DEVICE:** intra-articular administration of RegenoGel-SP or hyaluronic acid (HA)

## Key facts

- **NCT ID:** NCT02188771
- **Lead sponsor:** ProCore Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2015-10
- **Final completion:** 2015-10
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2017-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02188771

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02188771, "A Phase I, Prospective, Randomized, Open-label, Active-Controlled Clinical Trial for Safety Evaluation of Intra-articular Injection of RegenoGel-SP for the Treatment of Moderate to Severe Osteoarthritis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02188771. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*